MANAGEMENT OF DIMINISH VISION (TIMIR-MYOPIA) WITH AYURVEDIC TREATMENT

MANAGEMENT OF TIMIR (MYOPIA) WITH PATARADHYANJAN ALONG WITH OR WITHOUT VASAKADI KWATH(ORALLY)- AN OPEN LABELLED RANDOMIZED COMPARATIVE CLINICAL TRIAL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/07/034960

Enrollment

Registered

2021-07-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

Intervention1: PATRADHYANJANA AND VASAKADI KWATH: FORM OF ANJAN PINDI LOCALLY APLLICATION FOR 7 DAYS 2 SITTING WITH KWATH ORALLY Control Intervention1: PATRADHYANJANA: FORM OF ANJAN-PINDI DOSE- 2 HARE

Eligibility

Inclusion criteria

Inclusion criteria: Patients wearing spectacle glasses. Range of Refractive power Patients wearing contact lens. Patients having myopia with astigmatism. Non using spectacle patients. A person having classical symptoms of Timira and as well as Myopia.

Exclusion criteria

Exclusion criteria: Contraindicated for Anjan. Range of Refractive power > - 6 Patients after post LASIK surgery. Patient post cataract surgery. Congenital myopia. Pathological myopia. Patients having corneal opacity, post keratoplasty, keratoconus, corneal ectasia Patients having Iridocyclitis, iris tumor. Secondary myopia due Diabetes, Hypertension etc.

Design outcomes

Primary

Measure	Time frame
IMPROVEMENT OF SYMPTOMS OF TIMIR(MYOPIA)Timepoint: Upto 30 Days	—

Secondary

Measure	Time frame
IMPROVEMENT IN VISUAL EFFICACYTimepoint: PATIENT WILL BE ASSESSED UPTO 1 MONTH AFTER COMPLICTION OF TRETMENT	—

Countries

India

Contacts

Public ContactDR BHAKTI M CHHAYA

GOVERNMENT AKHANDANANDA AYURVEDA COLLAGE AND HOSPITAL

havyabk2013@gmail.com9909017824

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026